Table 1.
Authors, year | Population (n) | Age of population (years) | Key findings on bone biopsies | Correlations with PTH | Limitations | Comments |
---|---|---|---|---|---|---|
Salusky et al., 1988 [117] |
PD (44) | 6–18 |
Normal histology in 16% Osteitis fibrosa in 39% Aplastic lesions in 11% Osteomalacia in 9% |
Bone formation rate and larger resorption areas correlated with PTH (p < 0.001) PTH values were 2–3× higher in osteitis fibrosa patients |
Study prior to TMV criteria Aluminium hydroxide main phosphate binder |
Focus of study primarily on aluminium staining—as aluminium hydroxide used as main type of phosphate binder. |
Mathias et al., 1993 [118] | HD (21) | 16–19 |
High-turnover disease in 38% Osteitis fibrosa in 23% Adynamic bone in 28% |
Bone formation rate correlated with PTH as well as resorption areas (p < 0.001). |
Study prior to TMV criteria Aluminium hydroxide main phosphate binder |
PTH also correlated inversely with serum Ca levels (p < 0.001) |
Goodman et al., 1994 [119] | PD (14) | 13–14 |
Before calcitriol: osteitis fibrosa in 79% After calcitriol: normal in 43% Adynamic in 43% Osteitis fibrosa in 7% Mixed in 7% |
A PTH of below 200 pg/mL was strongly suggestive of adynamic bone disease. | Small number of patients | Aim of study was to look at effect of intermittent calcitriol therapy over 12 months on bone biopsy indices. |
Salusky et al., 1994 [65] |
PD (55) (68 bone biopsies) |
8–19 |
Osteitis fibrosa in 50% Mild hyperparathyroidism in 9% Adynamic bone lesions in 22% Normal in 19% |
High PTH values strongly correlated with osteitis fibrosa lesions vs mild, adynamic or normal histology (p < 0.001) |
PTH > 200 pg/mL and Ca < 10 mg/dl was 85% sensitive and 100% specific for high-turnover lesions. PTH < 200 pg/mL 100% sensitive, 79% specific for adynamic bone lesions |
|
Yalçinkaya et al., 2000 [120] | PD (17) | 7–20 |
High-turnover disease in 47% Low turnover disease in 29% Mixed in 24% |
High PTH values were significantly correlated to high-turnover disease (p < 0.01) vs low turnover | Small number of patients |
Mean serum Ca levels higher in low-turnover group vs high-turnover group (p < 0.001) Serum PTH > 200 pg/mL was 100% sensitive and 66% specific in identifying high turnover. |
Ziólkowska et al., 2000 [121] | HD (21), PD (30) | 7–15 |
Adynamic bone disease in 27% Normal bone in 37% Osteomalacia in 2% Hyperparathyroidism in 24% Mixed lesions in 10% |
Higher PTH significantly correlated with high-turnover disease vs adynamic or normal bone. |
Serum PTH > 200 pg/mL: 75% sensitive and 95% specific for identifying high-turnover disease In patients with normal bone turnover, 69% had PTH level of 50–150 pg/mL |
|
Waller et al., 2008 [66] | Pre-Tx (11) | 7–16 |
Low bone turnover disease in 18% Mixed lesions in 27% Hyperparathyroidism in 36% |
PTH > 3× ULN associated with high turnover Normal range PTH associated with low turnover |
Small number of patients | |
Bakkaloglu et al., 2010 [62] | PD (161) | 0–20 |
Low turnover in 4% Normal turnover in 39% High turnover in 57% Abnormal mineralisation in 48% |
Higher PTH significantly correlated with high-turnover disease vs low turnover or normal bone. |
For any level of turnover, PTH was higher if mineralisation defects were present (p < 0.01). PTH < 400 pg/mL and ALP < 400 IU/L provided the highest prediction of normal bone turnover and mineralisation |
|
Wesseling-Perry et al., 2012 [63] | CKD2-5 (52) | 2–21 |
High bone turnover in: 13% with CKD3 29% with CKD 4/5 Defective mineralisation in: 29% with CKD2 42% with CKD3 79% with CKD4/5 |
PTH was elevated in 36% of patients with CKD2, 71% with CKD3, and 93% with CKD4/5 | PTH was directly linked to poor mineralisation (p < 0.05) | |
Carvalho et al., 2015 [122] | PD (22) | 2–16 |
High bone turnover in 54% Low bone turnover in 23% Normal turnover in 23% |
PTH values higher in patients with high bone turnover (p < 0.05) and mineralisation (p < 0.01) | Small number of patients | Bone turnover correlated with alkaline phosphatase also (p < 0.01) |